Consistent with a previously identified association between FOXC2-induced EMT, CSCs, and cancer aggressiveness [62], we found that ectopic expression of FOXC2 in mouse ovarian cancer cells resulted in the upregulation of genes involved in EMT as well as CSC differentiation and increased tumor growth in mice. This evidence concerns the gene FOXC2 and cancer.